Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges
August 25 2020 - 6:31PM
Dow Jones News
By Brent Kendall and Jared S. Hopkins
WASHINGTON -- The U.S. business of Teva Pharmaceutical
Industries Ltd. has been indicted on charges the drugmaker fixed
prices on generic drugs, according to a person familiar with the
matter.
The Justice Department is expected to announce the charges
imminently, the person said.
Write to Brent Kendall at brent.kendall@wsj.com and Jared S.
Hopkins at jared.hopkins@wsj.com
(END) Dow Jones Newswires
August 25, 2020 18:16 ET (22:16 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Sep 2023 to Sep 2024